Medical Patch Kills Cancer Cells In Hard-To-Target Places [Video]

Medical Patch Kills Cancer Cells In Hard-To-Target Places [Video]

The Nanject delivers treatment via tiny particles injected into the bloodstream.

Leah Gonzalez
  • 10 july 2013

York University student researchers Zakareya Hussein and Atif Syed have launched a crowdfunding campaign to develop a nanoparticle cancer treatment that will be applied to the skin via a pharmaceutical patch.

Nanject is a patch that injects microscopic particles or nanoparticles into the bloodstream. These nanoparticles will then target cancer cells and attach themselves to the cancer cells and kill them. The particles and dead cells will then be removed naturally by the body.

The crowdfunding campaign is aimed not just to raise funds for the research of the cancer treatment, but to also study other ways of delivering such treatment. The team specifically wants to do more research on targeted drug delivery. In current cancer treatment like chemotherapy, healthy cells are also often destroyed by the drug and this can lead to complications for the patient. Using nanoparticles that are designed to target specific cells can help address this issue.

Aside from doing more research on targeted drug delivery, Hussein and Syed also want to be able to develop an alternative to injections. A Nanject patch contains invisible and tiny syringes that deliver the treatment painlessly.

Although Hussein and Syed are not the first to come up with the idea of using patches for treatment, they stated on their campaign page that the method they use is different from that of Dr. Mark Kendall who recently announced his research on vaccines via Nanopatch.

The Nanject campaign is targeting to raise $3000 which will be used mainly for chemicals and raw materials.

Watch the video about the project below.


+cancer treatment
+Market Research

Capsule Is Reimagining The Pharmacy As A Patient-First Experience

Entertainment Yesterday
Technology Yesterday
No search results found.